newsfilter
← Latest News
ACCESS Newswire·

Pressure BioSciences, Inc. Reports Q1 2022 Financial Results

Focused on the Successful Launch of its "Early Access Program" for the UST Platform, Company Already Negotiating with Four Potential Customers for Nanoemulsion Processing in Nutraceuticals and Cosmetics Investor Call Scheduled for Thursday, May 19, 2022